KR102414655B9 - 질환 상태의 백혈구를 검출하거나, 백혈구 관련 질환을 진단하는 장치 또는 방법 - Google Patents

질환 상태의 백혈구를 검출하거나, 백혈구 관련 질환을 진단하는 장치 또는 방법

Info

Publication number
KR102414655B9
KR102414655B9 KR1020210038976A KR20210038976A KR102414655B9 KR 102414655 B9 KR102414655 B9 KR 102414655B9 KR 1020210038976 A KR1020210038976 A KR 1020210038976A KR 20210038976 A KR20210038976 A KR 20210038976A KR 102414655 B9 KR102414655 B9 KR 102414655B9
Authority
KR
South Korea
Prior art keywords
leukocyte
diagnosing
disease state
related diseases
detecting
Prior art date
Application number
KR1020210038976A
Other languages
English (en)
Other versions
KR102414655B1 (ko
KR20210119914A (ko
Inventor
강주헌
권세용
아만졸 쿠르마쉬브
브라이언 최
이민석
Original Assignee
울산과학기술원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 울산과학기술원 filed Critical 울산과학기술원
Publication of KR20210119914A publication Critical patent/KR20210119914A/ko
Application granted granted Critical
Publication of KR102414655B1 publication Critical patent/KR102414655B1/ko
Publication of KR102414655B9 publication Critical patent/KR102414655B9/ko

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57426—Specifically defined cancers leukemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/7056—Selectin superfamily, e.g. LAM-1, GlyCAM, ELAM-1, PADGEM
    • G01N2333/70564—Selectins, e.g. CD62
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
KR1020210038976A 2020-03-25 2021-03-25 질환 상태의 백혈구를 검출하거나, 백혈구 관련 질환을 진단하는 장치 또는 방법 KR102414655B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20200036436 2020-03-25
KR1020200036436 2020-03-25

Publications (3)

Publication Number Publication Date
KR20210119914A KR20210119914A (ko) 2021-10-06
KR102414655B1 KR102414655B1 (ko) 2022-07-01
KR102414655B9 true KR102414655B9 (ko) 2023-04-12

Family

ID=77892770

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020210038976A KR102414655B1 (ko) 2020-03-25 2021-03-25 질환 상태의 백혈구를 검출하거나, 백혈구 관련 질환을 진단하는 장치 또는 방법

Country Status (3)

Country Link
US (1) US20230221315A1 (ko)
KR (1) KR102414655B1 (ko)
WO (1) WO2021194272A1 (ko)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930702681A (ko) * 1990-11-07 1993-09-09 윌리암 겔브 총 백혈구표면 항원을 이용한 질병치료와 진단방법
CN104962512B (zh) * 2009-07-21 2022-09-09 Abt控股公司 干细胞用于减少白细胞外渗的用途
US20200041493A1 (en) * 2016-10-14 2020-02-06 StickyCell Pty Ltd Leukocyte adhesive function assays, devices and/or uses
KR101929772B1 (ko) * 2016-11-02 2018-12-17 연세대학교 산학협력단 패혈증 진단을 위한 정보를 제공하는 방법 및 이를 이용한 키트

Also Published As

Publication number Publication date
KR102414655B1 (ko) 2022-07-01
KR20210119914A (ko) 2021-10-06
WO2021194272A1 (ko) 2021-09-30
US20230221315A1 (en) 2023-07-13

Similar Documents

Publication Publication Date Title
UA101167C2 (ru) Фармацевтическая композиция, предназначенная для лечения глазной болезни
WO2013008102A3 (en) Methods and compositions for evaluating and/or treating chronic immune diseases
MX2019009986A (es) Deteccion temprana de la activacion de celulas gliales en enfermedades neurodegenerativas o neuroinflamatorias.
PL2198288T3 (pl) Sposoby i urządzenia do prześwietlania jaj, przez wykrywania tętna zarodka
BR112013022493A2 (pt) equipamento e método para examinar, diagnosticar ou auxiliar no diagnóstico e no tratamento de problemas funcionais de visão
SE0602158L (sv) Metod att fastställa syrebrist i blod från skalpen under förlossning
EP4198819A4 (en) METHOD FOR DETECTING AND CLASSIFYING A LESION AREA IN A CLINICAL IMAGE
MX2018001697A (es) Método para la cuantificación de los miembros del filogrupo i y/o del filogrupo ii de faecalibacterium prausnitzii y el uso de los mismos como biomarcadores.
IL288098A (en) Methods and systems for detecting disease residues
GB0620831D0 (en) System and method for metadata verification during measurement processing
GB2602600B (en) System and method for identifying a disease affected area
IL290175A (en) A method for identifying a patient sensitive to carbohydrate drugs in patients suffering from Alzheimer's disease
MX2021009528A (es) Prueba de diagnostico basada en fragmento de rgma.
IL290438A (en) A system and method for determining the onset of a disease and its progression
FR3020682B1 (fr) Procede et systeme de detection d'au moins une particule dans un liquide corporel, et procede associe de diagnostic de la meningite
EP4162445A4 (en) AUTOMATED DISEASE DETECTION SYSTEM
EP3699928C0 (en) METHOD AND SYSTEM FOR DETECTING PARKINSON
KR102414655B9 (ko) 질환 상태의 백혈구를 검출하거나, 백혈구 관련 질환을 진단하는 장치 또는 방법
EP4247979A4 (en) METHODS AND SYSTEMS FOR DETECTING RESIDUAL DISEASE
IN2014KN00742A (ko)
IL274016A (en) Methods for automated lesion analysis in longitudinal volumetric medical image studies
IL299030A (en) Systems and methods for measuring pupillary distance and their uses
MX2018003454A (es) Composiciones y metodos para diagnosticar la enfermedad de lyme y para predecir la eliminacion de las espiroquetas de la enfermedad de lyme despues del tratamiento.
IN2013CN02996A (ko)
ZA202211940B (en) Methods for identifying a medical condition in a human subject

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
G170 Re-publication after modification of scope of protection [patent]